scholarly journals The Impact of the COVID-19 Pandemic on Cardiac Procedure Wait List Mortality in Ontario, Canada

Author(s):  
Derrick Y. Tam ◽  
Feng Qiu ◽  
Ragavie Manoragavan ◽  
Stephen E. Fremes ◽  
Ansar Hassan ◽  
...  
SLEEP ◽  
2020 ◽  
Vol 43 (9) ◽  
Author(s):  
Simon D Kyle ◽  
Madeleine E D Hurry ◽  
Richard Emsley ◽  
Antonia Marsden ◽  
Ximena Omlin ◽  
...  

Abstract Study Objectives We sought to examine the impact of digital cognitive behavioral therapy (dCBT) for insomnia on both self-reported cognitive impairment and objective cognitive performance. Methods The Defining the Impact of Sleep improvement on Cognitive Outcomes (DISCO) trial was an online, two-arm, single-blind, randomized clinical trial of dCBT versus wait-list control. Participants were aged 25 years and older, met DSM-5 diagnostic criteria for insomnia disorder, and reported difficulties with concentration or memory. Assessments were carried out online at baseline, and 10 and 24 weeks post-randomization. The primary outcome measure was self-reported cognitive impairment, assessed with the British Columbia Cognitive Complaints Inventory (BC-CCI). Secondary outcomes included tests of cognitive performance, insomnia symptoms, cognitive failures, fatigue, sleepiness, depression, and anxiety. Results Four hundred and ten participants with insomnia were recruited and assigned to dCBT (N = 205) or wait-list control (N = 205). At 10 weeks post-randomization the estimated adjusted mean difference for the BC-CCI was −3.03 (95% CI: −3.60, −2.47; p < 0.0001, d = −0.86), indicating that participants in the dCBT group reported less cognitive impairment than the control group. These effects were maintained at 24 weeks (d = −0.96) and were mediated, in part, via reductions in insomnia severity and increased sleep efficiency. Treatment effects in favor of dCBT, at both 10 and 24 weeks, were found for insomnia severity, sleep efficiency, cognitive failures, fatigue, sleepiness, depression, and anxiety. We found no between-group differences in objective tests of cognitive performance. Conclusions Our study shows that dCBT robustly decreases self-reported cognitive impairment at post-treatment and these effects are maintained at 6 months.


2017 ◽  
Vol 9 (2) ◽  
pp. 48
Author(s):  
Samaneh Hedayati Manesh ◽  
Azam Alikhademi

This study was an attempt to examine the impact of Neurofeedback on clinical signs of Children that have attention deficit disorder and hyperactivity. The participants of this study 24 boys (6-11) that afflicted to ADHD. The participants of the study randomly divided into two groups and were selected to participate in the study. The experimental group received the Neurofeedback treatment (8 weeks, three sessions in a week). The control group, on the other hand was placed in a wait list. After treatment, CBCL, IVA, QEEG were administered between two groups. The analysis of data revealed that Nero feedback has a significant impact on ADHD children. Moreover, Neurofeedback treatment leads to improve attention deficit disorder and decrease impulsivity in ADHD children.


2012 ◽  
Vol 26 (2) ◽  
pp. 170-176 ◽  
Author(s):  
Lorenzo A. Orci ◽  
Pietro Edoardo Majno ◽  
Thierry Berney ◽  
Philippe Morel ◽  
Gilles Mentha ◽  
...  

2005 ◽  
Vol 15 (1) ◽  
pp. 78-85
Author(s):  
John F. Todaro ◽  
Samuel F. Sears ◽  
James R. Rodrigue ◽  
Kristin Musto

Context Although research examining medical outcomes in heart transplantation has progressed, there are few studies examining the impact of organ scarcity and wait list demand on the transplant candidate evaluation process. Objective To examine the influence of transplant knowledge pertaining to organ scarcity and wait list demand on simulated ratings of psychological distress provided by community residents participating in a simulated pre–heart transplant evaluation. Design A randomized, controlled design. We used a vignette simulation to experimentally manipulate the effect of transplant knowledge pertaining to organ scarcity in a group of community residents with no previous knowledge or experience with the transplant selection process. Participants One hundred forty-three community residents visiting a department of motor vehicles office in north central Florida were recruited. Community residents were randomly assigned to 1 of 2 experimental conditions, with either mention (n = 66) or no mention (n = 77) of organ scarcity and wait list demand statistics in their assigned vignette. Participants then served as actors and completed measures of psychological distress as part of a mock psychological pre–heart transplant evaluation. Results Participants with mention of organ scarcity reported significantly fewer symptoms of anxiety and depression compared to those with no mention of organ scarcity. This relationship remained significant even after controlling for relevant covariates, including age and simulated ratings of social desirability. Conclusion Transplant knowledge pertaining to organ scarcity and wait list demand may influence transplant candidates to report fewer symptoms of psychological distress. Clinical suggestions for dealing with underreporting of psychological distress are discussed.


Author(s):  
Stephanie Garcia-Botello ◽  
J. Martín-Arevalo ◽  
C. Cozar-Lozano ◽  
A. Benitez-Riesco ◽  
D. Moro-Valdezate ◽  
...  

Abstract Background Surgical wait list time is a major problem in many health-care systems and its influence on survival is unclear. The aim of this study is to assess the impact of wait list time on long-term disease-free survival in patients scheduled for colorectal cancer resection. Materials and methods A prospective study was carried out in patients with colorectal cancer scheduled for surgery at a tertiary care center. Wait list time was defined as the time from completion of diagnostic workup to definitive surgery and divided into 2-week intervals from 0 to 6 weeks. The outcome variables were 2-year and 5-year disease-free survival. Results A total of 602 patients, 364 (60.5%) male, median age 73 years (range = 71) were defined. The median wait list time was 28 days (range = 99). Two and 5-year disease-free survival rates were 521 (86.5%) and 500 (83.1%) respectively. There were no differences in 2-year or 5-year disease-free survival for the whole cohort or by tumor stage between wait list time intervals except for AJCC stage II tumors which showed a higher 5-year disease-free survival for the 2–4 and 4–6-week wait list time interval (p = 0.021). Conclusions Time from diagnosis to definitive surgery up to 6 weeks is not associated with a decrease in 2-year or 5-year disease-free survival (DFS) in AJCC stage I through III colorectal cancer patients. These are important findings in the light of the COVID-19 pandemic and offer a window of opportunity for preoperative optimization and prehabilitation.


2021 ◽  
Author(s):  
Megan Elliott ◽  
Mark Llewellyn ◽  
Carolyn Wallace ◽  
Sarah Wallace ◽  
E Mark Williams

Abstract BackgroundSocial prescribing aims to connect citizens with sources of support in their communities to benefit their health and well-being. Despite its ongoing implementation within the United Kingdom, the evidence base for social prescribing has been criticised, citing a lack of rigour, high risk of bias and inconclusive findings to date.MethodsThis study protocol aims to examine the feasibility of using large, randomised control studies to assess the mental health and well-being impacts of social prescribing. Two wait-list control studies, each consisting of two parallel arm groups, SPRING and PROPSECT were designed. Participants were referred via their consulting healthcare professionals. The participants were randomised to receive the intervention immediately or after a delay of four weeks. The intervention in the SPRING study was a personal “what-matters” interview by a Link Worker consultation leading to a prescribed social service. Three month and six month follow up of service use was proposed. In PROPSECT, the intervention was a holistic social prescribing service. In both trials the primary outcomes were quality of life, service uptake, and participant experience.DiscussionSocial prescribing is becoming popular in community health and care services. It is believed to be an effective resource, and this is first randomised control trial to attempt to demonstrate the effectiveness of social prescribing for people with Mental Health and/or emotional well-being issues. A waiting-list control study is feasible in this context but would be suitable for larger randomised controlled trials.Trial Registration: SPRING, Clinical Trials, NCT04062903. Registered 17th September 2019, https://clinicaltrials.gov/ct2/show/NCT04062903?term=NCT04062903&draw=2&rank=1. PROSPECT, Clinical Trials, NCT04099095. Registered 23rd September 2019, https://clinicaltrials.gov/ct2/show/NCT04099095?term=NCT04099095&draw=2&rank=1


2011 ◽  
Vol 30 (4) ◽  
pp. S51
Author(s):  
G. Smith ◽  
J. Chu ◽  
L. Danziger-Isakov ◽  
R. Avery ◽  
D. Van Duin ◽  
...  
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document